Tag: License Agreement
October 1, 2018
Melinta Therapeutics and Menarini Group Enter Commercial Agreement
Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, and Menarini Group,...
September 28, 2018
Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
In case you missed it, here is this week's big news roundup in the Life Science sector. September 27, 2018
DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke
Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,...
August 20, 2018
RedHill BioPharma Receives New Patent
RedHill Biopharma received a notice of allowance from the US Patent and Trademark Office on Monday for a new formulation... August 7, 2018
Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China
Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin)...
July 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 15, 2018